-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – HD-6277 in Type 2 Diabetes
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - HD-6277 in Type 2 Diabetes report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. HD-6277 in Type 2 Diabetes Drug Details: HD-6277 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zavacorilant in Alzheimer’s Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zavacorilant in Alzheimer's Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zavacorilant in Alzheimer's Disease Drug Details: Zavacorilant is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zavacorilant in Huntington Disease
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zavacorilant in Huntington Disease report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zavacorilant in Huntington Disease Drug Details: Zavacorilant is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Zavacorilant in Amyotrophic Lateral Sclerosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Zavacorilant in Amyotrophic Lateral Sclerosis report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Zavacorilant in Amyotrophic Lateral Sclerosis Drug Details: Zavacorilant is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Trehalose in Oculopharyngeal Muscular Dystrophy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Trehalose in Oculopharyngeal Muscular Dystrophy report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Trehalose in Oculopharyngeal Muscular Dystrophy Drug Details: Trehalose is under...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tenecteplase in Acute Ischemic Stroke
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tenecteplase in Acute Ischemic Stroke report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tenecteplase in Acute Ischemic Stroke Drug Details: Tenecteplase (Metalyse, Tnkase)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tenecteplase in Acute Respiratory Failure
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tenecteplase in Acute Respiratory Failure report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tenecteplase in Acute Respiratory Failure Drug Details: Tenecteplase (Metalyse, Tnkase)...
-
Sector Analysis
NewGiro d’Italia 2024 – Post Event Analysis
An analysis of the recent 2024 Giro d'Italia, including a look at its sponsorship portfolio, broadcasters, attendance and ticketing. The annual broadcasting revenue for the 2024 Giro d'Italia was estimated to be worth $30.10 million. Discovery, the international media rights broadcaster, acquired the global rights to the Giro d'Italia. UK viewers were able to watch all of the action from the 2024 Giro d'Italia on discovery+, which is the main hub for all Eurosport live coverage. Over the 21 stages,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Sargramostim in Hematopoietic Stem Cell Transplantation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Sargramostim in Hematopoietic Stem Cell Transplantation report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Sargramostim in Hematopoietic Stem Cell Transplantation Drug Details: Sargramostim...